Sign in

CIK 0001844417

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Estrella Immunopharma, Inc.

Sign in to watch
Ticker
ESLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
861314502
Phone
+1 510-318-9098
Business address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Former names
TradeUP Acquisition Corp.

Securities

  • ESLA Common Stock Nasdaq
  • ESLAW Warrant Nasdaq
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 8-K Event Material agreement
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Material agreement
  5. 8-K Event Delisting notice
  6. 425 Deal Prospectus/Communication re Business Combination
  7. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  8. 8-K Event Delisting notice
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  11. 425 Deal Prospectus/Communication re Business Combination
  12. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  15. S-4/A Deal Registration Statement - Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  18. 8-K Event Material agreement · Bylaws or fiscal year change · Other events
  19. 8-K Event Shareholder vote results
  20. S-4/A Deal Registration Statement - Business Combination

Page 4 of 5 · 87 filings